ArticleOPEN ACCESS

Infiltrative lung diseases: Complications of novel antineoplastic agents in patients with hematological malignancies

Canadian Respiratory Journal
DOI: 10.1155/2008/305234
23Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. The present review discusses different pulmonary syndromes, pathogenesis and management of these novel agents. © 2008 Pulsus Group Inc. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Vahid, B., & Marik, P. E. (2008). Infiltrative lung diseases: Complications of novel antineoplastic agents in patients with hematological malignancies. Canadian Respiratory Journal. Hindawi Limited. https://doi.org/10.1155/2008/305234

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free